GESTation and Environment

The initial objective of this study was to investigate the association between maternal blood PBDE concentrations measured in early pregnancy and serum thyroid hormone levels assessed at less than 20 weeks of pregnancy, at delivery, and in cord blood.

More specifically the study aimed to:

  • examine the relationship between PBDE concentrations and thyroid hormones and their metabolites in maternal and cord blood;
  • determine the dose-response relationship between Mn, Cd, Pb, PCB, PBDE and Hg concentrations at birth, and psychomotor scores of children taking into account potential confounding factors including postnatal exposures;
  • determine whether prenatal exposure to PBDE flame retardants is associated with MRI abnormalities in brain function and connectivity and with ADHD behaviors and diagnosis;
  • determine whether prenatal exposure to halogenated non-PBDE flame retardants is associated with MRI abnormalities in brain function and connectivity and with ADHD behaviors and diagnosis; and
  • explore whether the levels of PBDEs and their substitutes, measured in both blood and stools during childhood, are associated with MRI brain measures, neurobehaviors and ADHD diagnosis, directly or via alterations of the gut microbiome.

Overview

Acronym
GESTE
Investigators
Dr. Larissa Takser
Université de Sherbrooke
Dr. Andrea Baccarelli
Columbia University
Contacts
Dr. Larissa Takser
Université de Sherbrooke

General Design

Study design
Cohort
Start - End Year
2007 -
General Information on Follow Up (profile, frequency)

Women were enrolled at less than 20 weeks of pregnancy, at their first prenatal care visit, with follow-up at delivery. Other women were recruited at delivery. All children were then followed at 2 years, 6-7 years and at 8-12 years.

Recruitment Target
  • Families
Number of Participants
1,561
Number of Participants with Biological Samples
1,561
Supplementary information about number of participants
Mothers: 800 participants
Children: 761 participants

Access

Availability of data and biosamples

Possible Access to Data
Possible Access to Biosamples
Other

Marker Papers

Abdelouahab N, Langlois MF, Lavoie L, Corbin F, Pasquier JC, Takser L. 2013. Maternal and cord-blood thyroid hormone levels and exposure to polybrominated diphenyl ethers and polychlorinated biphenyls during early pregnancy. AJE (2013) 178(5):701-713.

PUBMED 23924579

Supplementary Information

Serme-Gbedo YK, Abdelouahab N, Pasquier JC, Cohen AA, Takser L. Maternal levels of endocrine disruptors, polybrominated diphenyl ethers, in early pregnancy are not associated with lower birth weight in the Canadian birth cohort GESTE. Environ Health. 2016 Apr 12;15:49.
PMID: 27068391

Timeline

Populations

GESTE - Mothers
The population is composed of pregnant women who were enrolled at less than 20 weeks of pregnancy, at their first prenatal care visit at the University Hospital Center of Sherbrooke. A second sample of women was recruited at delivery.

Selection Criteria

Sex
Women only
Minimum age
18
Pregnant Women
  • First trimester
  • Second trimester
Countries
  • Canada
Canadian Provinces
  • Quebec
Territory
Sherbrooke
Health Status
  • No known thyroid disease
Other Criteria
Gestational age less than 20 weeks or at delivery.
Supplementary Information about selection criteria
After verification of medical files, a post hoc exclusion criterion was added: use of medication known to affect thyroid hormone levels.

Sources of Recruitment

Specific Population
  • Clinic patients
Supplementary Information
Participants were recruited at their first care visit. A second sample of women was recruited at delivery.

Sample Size

Number of Participants
800
Number of Participants with Biological Samples
800
Supplementary information about number of participants
20 weeks gestation: 400 participants
Delivery: 761 participants
6-7 years: 367 participants
8-12 years: 161 participants (ongoing)

Data Collection Events

# Name Data sources Data sources - Biosamples Start End
0 GESTE - Mothers - < 20 weeks gestation
  • Questionnaires
  • Physical measures
  • Biosamples
  • Other : Medical records
  • Blood
  • Urine
  • Hair
2007 (September) 2008 (December)
1 GESTE - Mothers - Delivery
  • Questionnaires
  • Physical measures
  • Biosamples
  • Other :
  • Blood
  • Urine
  • Hair
  • Tissues : Placenta
  • Other : Breast milk.
2008 (February) 2009 (July)
2 GESTE - Mothers - Follow-up at 6-7 years
  • Questionnaires
  • Cognitive measures
  • Physical measures
  • Biosamples
  • Blood
2014 (July) 2016 (November)
3 GESTE - Mothers - Follow-up at 8-12 years
  • Questionnaires
  • Cognitive measures
  • Physical measures
2017 (September) 2023 (March)
GESTE - Children
Children of the women in the GESTE study. Born between February 2008 and July 2009.

Selection Criteria

Newborns
Countries
  • Canada
Canadian Provinces
  • Quebec
Territory
Sherbrooke

Sources of Recruitment

Specific Population
  • Other specific population : Children of the women in the GESTE study.

Sample Size

Number of Participants
761
Number of Participants with Biological Samples
761
Supplementary information about number of participants
Delivery: 761 participants
2 years: 291 participants
6-7 years: 367 participants
8-12 years: 161 participants (ongoing)

Data Collection Events

# Name Data sources Data sources - Biosamples Start End
0 GESTE - Children - Delivery
  • Physical measures
  • Biosamples
  • Hair
  • Cord blood
  • Tissues : Placenta
  • Other : Meconium
2008 (February) 2009 (July)
1 GESTE - Children - Follow-up at 2 years old
  • Questionnaires
  • Biosamples
  • Hair
  • Nail
2010 (February) 2011 (July)
2 GESTE - Children - Follow-up at 6-7 years old
  • Cognitive measures
  • Physical measures
  • Biosamples
  • Blood
  • Urine
  • Hair
  • Nail
  • Other : Stool, tooth
2014 (July) 2016 (November)
3 GESTE - Children - Follow-up at 8-12 years old
  • Questionnaires
  • Cognitive measures
  • Physical measures
  • Biosamples
  • Blood
  • Urine
  • Hair
  • Other : Stool, tooth, dust
2017 (September) 2023 (March)

Participating Studies

Acronym Name Study design Countries

Harmonization Initiatives Included

Acronym Name

Datasets

Name Data Collection Events Variables

Areas of Information Collected

Socio-demographic and economic characteristics
Death
Lifestyle and behaviours
Physical measures and assessments
Birth, pregnancy and reproductive health history
Laboratory measures
Perception of health, quality of life, development and functional limitations
Cognition, personality and psychological measures and assessments
Diseases
Life events, life plans, beliefs and values
Symptoms and signs
Preschool, school and work life
Medication and supplements
Social environment and relationships
Non-pharmacological interventions
Physical environment
Health and community care services utilization
Administrative information

Variables Content Summary

Areas of Information Collected
No Areas of Information Collected
No Scales Collected
Areas of Information Collected per per Population and Data Collection Event
No Areas of Information Collected
No Scales Collected

Networks

Acronym Name Harmonization Initiatives Individual Studies
Last Update: 2022-06-21T07:06:09.088